Maria-Luisa Maccecchini - 18 Jan 2023 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Henry Hagopian III, Attorney-in-Fact for Maria L. Maccecchini
Issuer symbol: ANVS
Transactions as of: 18 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 20 Jan 2023, 16:43:08 UTC
Previous filing: 24 Oct 2022
Next filing: 08 Feb 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANVS	Stock Option (right to buy)	Award	$0	+21,312		$0.000000	21,312	18 Jan 2023	Common Stock	21,312	$13.17	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option shall vest in eight consecutive quarterly installments of 2,664 shares each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025.